Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm G W
Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, München, Germany.
J Virol. 1994 Nov;68(11):6947-58. doi: 10.1128/JVI.68.11.6947-6958.1994.
Epstein-Barr virus (EBV) transforms resting B cells in vitro very efficiently. The nuclear viral protein EBV nuclear antigen 2 (EBNA2) is absolutely required for this process and also acts as a transcriptional activator of cellular and viral genes. As shown previously, EBNA2 transactivates the promoters of the viral latent membrane proteins. It interacts indirectly with an EBNA2-responsive cis element of the terminal protein 1 (TP1) promoter. To identify the sequences mediating EBNA2 transactivation of the bidirectional promoter region driving expression of the latent membrane proteins LMP and TP2 in opposite directions, we assayed the effects of EBNA2 on the activities of promoter deletion and site-directed mutants of TP2 and LMP promoter luciferase reporter gene constructs by cotransfections into EBNA2-negative Burkitt's lymphoma cells. We were able to delineate an 80-bp EBNA2-responsive region (EBNA2RE) between -232 and -152 relative to the LMP RNA start site which could also mediate EBNA2-dependent activation on a heterologous promoter. Sequences of 20 and 32 bp located at the 5' and 3' ends, respectively, of the EBNA2RE were both essential for EBNA2 responsiveness. Full transactivation of the LMP and TP2 promoters seemed to require 20 bp of 5' adjacent sequences in addition to the 80-bp element. Electrophoretic mobility shift assays revealed specific protein-DNA complexes formed at the EBNA2RE. Oligonucleotides from -181 to -152 and -166 to -132 relative to the LMP RNA start site visualized one B-cell and one B-cell-plus-HL60-specific retarded protein-DNA complex, respectively. Additionally, an oligonucleotide from -253 to -210 revealed two specific protein-DNA complexes with nuclear extracts from different B and non-B cells, suggesting also the binding of ubiquitously expressed proteins on the EBNA2RE. Thus, these experiments defined a 80-bp cis element sufficient for conferring EBNA2 inducibility and demonstrated specific interactions of cellular proteins at DNA sequences within the EBNA2RE, which are critical for transactivation by EBNA2.
爱泼斯坦-巴尔病毒(EBV)在体外能非常有效地转化静息B细胞。核病毒蛋白EBV核抗原2(EBNA2)是这一过程绝对必需的,并且还作为细胞和病毒基因的转录激活因子。如先前所示,EBNA2反式激活病毒潜伏膜蛋白的启动子。它间接与末端蛋白1(TP1)启动子的EBNA2反应性顺式元件相互作用。为了鉴定介导EBNA2对双向启动子区域反式激活的序列,该双向启动子区域以相反方向驱动潜伏膜蛋白LMP和TP2的表达,我们通过共转染到EBNA2阴性的伯基特淋巴瘤细胞中,检测了EBNA2对TP2和LMP启动子荧光素酶报告基因构建体的启动子缺失和定点突变体活性的影响。我们能够确定相对于LMP RNA起始位点在-232至-152之间的一个80 bp的EBNA2反应区域(EBNA2RE),其也可介导EBNA2依赖的对异源启动子的激活。分别位于EBNA2RE 5'和3'末端的20 bp和32 bp序列对于EBNA2反应性都是必需的。LMP和TP2启动子的完全反式激活似乎除了80 bp元件外还需要20 bp的5'相邻序列。电泳迁移率变动分析揭示了在EBNA2RE处形成的特异性蛋白质-DNA复合物。相对于LMP RNA起始位点从-181至-152和从-166至-132的寡核苷酸分别显示出一种B细胞特异性和一种B细胞加HL60特异性的滞后蛋白质-DNA复合物。此外,一个从-253至-210的寡核苷酸与来自不同B细胞和非B细胞的核提取物显示出两种特异性蛋白质-DNA复合物,这也表明普遍表达的蛋白质与EBNA2RE结合。因此,这些实验确定了一个足以赋予EBNA2诱导性的80 bp顺式元件,并证明了细胞蛋白在EBNA2RE内的DNA序列处的特异性相互作用,这对于EBNA2的反式激活至关重要。